Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Eton Pharmaceutcials Inc (ETON)

Eton Pharmaceutcials Inc (ETON)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Eton Pharmaceuticals, Inc. (ETON) Reports Q1 Loss, Lags Revenue Estimates

Eton Pharmaceuticals, Inc. (ETON) delivered earnings and revenue surprises of -108.33% and -93.89%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the...

ETON : 5.22 (-2.06%)
Eton Pharmaceuticals Announces First Quarter 2020 Financial Results

Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today reported financial results for the first quarter ended...

ETON : 5.22 (-2.06%)
Eton Pharmaceuticals Inc (ETON) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Eton Pharmaceuticals Inc (ETON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ETON : 5.22 (-2.06%)
Eton Pharmaceuticals to Report First Quarter Financial Results on Thursday, May 14, 2020

Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today announced that it will report first quarter 2020 financial...

ETON : 5.22 (-2.06%)
Eton Pharmaceuticals Announces Appointment of Paul Stickler as Senior Vice President of Sales and Marketing

Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today announced that it has appointed Paul Stickler as the...

ETON : 5.22 (-2.06%)
Will Eton Pharmaceuticals Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor Eton Pharmaceuticals

ETON : 5.22 (-2.06%)
Company News for Mar 30, 2020

Companies in the news are: ETON, SDC, RRTS, BKYI

RRTS : 2.3800 (-0.42%)
BKYI : 1.1300 (+41.25%)
ETON : 5.22 (-2.06%)
SDC : 8.69 (-0.69%)
Eton Pharmaceuticals, Inc. (ETON) Upgraded to Buy: Here's What You Should Know

Eton Pharmaceuticals, Inc. (ETON) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ETON : 5.22 (-2.06%)
Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Misses Revenue Estimates

Eton Pharmaceuticals, Inc. (ETON) delivered earnings and revenue surprises of 48.28% and -54.55%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the...

ETON : 5.22 (-2.06%)
Eton Pharmaceuticals Announces Fourth Quarter and Full Year 2019 Financial Results

Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today reported financial results for the fourth quarter...

ETON : 5.22 (-2.06%)
Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2019 Financial Results on Thursday, March 5, 2020

Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today announced that it will report fourth quarter and full...

ETON : 5.22 (-2.06%)
Teladoc (TDOC) to Post Q4 Earnings: What's in the Cards?

Teladoc's (TDOC) Q4 performance is likely to have benefited from increased membership and visits.

AMAG : 8.61 (+2.62%)
GNMK : 17.54 (-2.99%)
TDOC : 216.62 (-2.35%)
ETON : 5.22 (-2.06%)
Eton Pharmaceuticals Provides Update on ET-105 Program

Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today provided an update on its ET-105 product candidate,...

ETON : 5.22 (-2.06%)
5 Drug/Biotech Stocks Likely to Beat Q4 Earnings Estimates

Let us take a look at some drug/biotech stocks that are poised to beat on earnings in the fourth quarter.

JNJ : 147.84 (-0.28%)
GILD : 76.19 (-0.60%)
IMMU : 41.47 (+0.75%)
PRGO : 57.95 (-0.26%)
CLVS : 6.36 (-1.55%)
VTVT : 2.35 (+0.43%)
ETON : 5.22 (-2.06%)
Eton Pharmaceuticals to Present at the 9th Annual SVB Leerink Healthcare Conference

Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today announced that Sean Brynjelsen, Chief Executive Officer,...

ETON : 5.22 (-2.06%)
Eton Pharmaceuticals and Xellia Pharmaceuticals Announce Biorphen(R) (phenylephrine HCl) Co-Promotion Agreement

Eton Pharmaceuticals, Inc. (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, announced it has entered into a co-promotion agreement...

ETON : 5.22 (-2.06%)
Eton Pharmaceuticals Announces $10 Million Debt Facility with SWK Holdings

Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today announced it has entered into a $10 million debt facility...

ETON : 5.22 (-2.06%)
Eton Pharmaceuticals to Report Third Quarter 2019 Financial Results on Thursday, November 14, 2019

Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today announced that it will report third quarter 2019 financial...

ETON : 5.22 (-2.06%)
Eton Pharmaceuticals, Inc. (ETON) Upgraded to Strong Buy: Here's What You Should Know

Eton Pharmaceuticals, Inc. (ETON) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

ETON : 5.22 (-2.06%)
Eton Pharmaceuticals to Participate in Lake Street 3rd Annual Best Ideas Growth Conference

Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today announced that Sean Brynjelsen, Chief Executive Officer,...

ETON : 5.22 (-2.06%)

Van Meerten Stock Picks

Ebay - Pick of the Day
Today Ebay (EBAY) is a Volume Leader on Barchart: 100% technical buy signals Trend Spotter buy signal Above its 20, 50 and 100 Day moving averages 16 new highs and up 26.
EBAY +0.43
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar